Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) pathway signaling

被引:82
作者
Thorburn, Andrew
机构
[1] Univ Colorado Denver, Ctr Comprehens Canc, Aurora, CO 80010 USA
[2] Dept Pharmacol, Aurora, CO USA
[3] Hlth Sci Ctr, Aurora, CO USA
关键词
D O I
10.1097/JTO.0b013e31805fea64
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/ ApolL is a death ligand, a cytokine that activates apoptosis through cell surface death receptors. TRAIL is thought to be important in host tumor surveillance and metastasis suppression, and various therapeutic agonists that activate TRAIL receptors to induce tumor cell apoptosis are in clinical development. This review discusses recent findings about TRAIL pathway signaling and relates the signaling mechanisms to issues that need to be considered as we try to manipulate TRAIL signaling to treat cancer.
引用
收藏
页码:461 / 465
页数:5
相关论文
共 66 条
[61]   Tumoricidal activity of tumor necrosis factor related apoptosis-inducing ligand in vivo [J].
Walczak, H ;
Miller, RE ;
Ariail, K ;
Gliniak, B ;
Griffith, TS ;
Kubin, M ;
Chin, W ;
Jones, J ;
Woodward, A ;
Le, T ;
Smith, C ;
Smolak, P ;
Goodwin, RG ;
Rauch, CT ;
Schuh, JCL ;
Lynch, DH .
NATURE MEDICINE, 1999, 5 (02) :157-163
[62]   Inducible silencing of KILLER/DR5 in vivo promotes bioluminescent colon tumor xenograft growth and confers resistance to chemotherapeutic agent 5-fluorouracil [J].
Wang, SL ;
El-Deiry, WS .
CANCER RESEARCH, 2004, 64 (18) :6666-6672
[63]   TRAIL and apoptosis induction by TNF-family death receptors [J].
Wang, SL ;
El-Deiry, WS .
ONCOGENE, 2003, 22 (53) :8628-8633
[64]   KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene [J].
Wu, GS ;
Burns, TF ;
McDonald, ER ;
Jiang, W ;
Meng, R ;
Krantz, ID ;
Kao, G ;
Gan, DD ;
Zhou, JY ;
Muschel, R ;
Hamilton, SR ;
Spinner, NB ;
Markowitz, S ;
Wu, G ;
ElDeiry, WS .
NATURE GENETICS, 1997, 17 (02) :141-143
[65]   Loss of TRAIL-R does not affect thymic or intestinal tumor development in p53 and adenomatous polyposis coli mutant mice [J].
Yue, HH ;
Diehl, GE ;
Winoto, A .
CELL DEATH AND DIFFERENTIATION, 2005, 12 (01) :94-97
[66]   Cutting edge: TRAIL deficiency accelerates hematological malignancies [J].
Zerafa, N ;
Westwood, JA ;
Cretney, E ;
Mitchell, S ;
Waring, P ;
Iezzi, M ;
Smyth, MJ .
JOURNAL OF IMMUNOLOGY, 2005, 175 (09) :5586-5590